Dorocubicel (UM171-expanded cord blood)
Zemcelpro is a laboratory-expanded umbilical cord blood transplant for adults with blood cancers who need a donor stem cell transplant but have no suitable matched donor; expanding the cells lets a single small cord blood unit be enough.
Overview
Dorocubicel was authorised by the European Commission in August 2025 as an advanced therapy medicinal product for adults with haematological malignancies requiring allogeneic haematopoietic stem cell transplantation after myeloablative conditioning for whom no other suitable donor cells are available. It consists of the CD34-positive fraction of a single cord blood unit expanded with UM171, a pyrimidoindole agonist of stem cell self-renewal discovered at Universite de Montreal, together with the unexpanded CD34-negative cells. Phase 2 studies showed faster neutrophil engraftment than historical unmanipulated cord blood and low rates of severe chronic graft-versus-host disease, addressing the slow engraftment that limited cord blood transplants in adults. It is not approved in the US. Risks are those of allogeneic transplantation: infection, graft failure and graft-versus-host disease. Developed by ExCellThera.
Approvals
| Region | Year | Indication |
|---|---|---|
| EU | 2025 | Adults with haematological malignancies requiring allogeneic HSCT after myeloablative conditioning with no other suitable donor cells |
Trials
topRecruiting now (live from ClinicalTrials.gov)
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Latest papers
topQuery for this drug: (TITLE:"Dorocubicel" OR ABSTRACT:"Dorocubicel" OR TITLE:"UM171-expanded cord blood" OR ABSTRACT:"UM171-expanded cord blood" OR TITLE:"Zemcelpro" OR ABSTRACT:"Zemcelpro" OR TITLE:"UM171 cell therapy" OR ABSTRACT:"UM171 cell therapy" OR TITLE:"ECT-001" OR ABSTRACT:"ECT-001") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Dorocubicel (UM171-expanded cord blood), not a curated reading list.
Pages like this
not linked directly; found by shared links- ProductHistamine dihydrochloride
Shares Acute myeloid leukaemia and the tag ema-list.
- TargetCD7
Shares Allogeneic stem cell transplantation, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- CompanyOrca Bio
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- CompanyAllotera Therapeutics (formerly Wugen)
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- ProductBelumosudil
Shares Allogeneic stem cell transplantation, Myelodysplastic syndromes / neoplasms (MDS), Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- ProductTreosulfan
Shares Allogeneic stem cell transplantation, Myelodysplastic syndromes / neoplasms (MDS), Acute myeloid leukaemia.
- InstitutionMasonic Cancer Center, University of Minnesota
Shares Allogeneic stem cell transplantation, Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.
- InstitutionPeking University People's Hospital
Shares Allogeneic (off-the-shelf) cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia.